The global allergy rihinitis drugs market is currently valued at USD 10,555 million and is expected to surpass USD 11,923 million by 2021, says Technavio. Technavio has announced its latest market research report on the global allergy rhinitis drugs market, under its infectious and rare diseases portfolio. This market analysis discusses the major drivers and…
Technavio, a tech-focused market research firm, has published a new report on the global veterinary vaccines market, which is expected to grow at a CAGR of close to 5% during the forecast period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global veterinary vaccines market into the following key regions: the Americas, APAC,…
Technavio, a tech-focused market research firm, has published a new report on the global rabies treatment market, which is expected to grow at a CAGR of close to 5% during the forecast period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global rabies treatment market into the following key regions: the Americas, APAC,…
Technavio, a tech-focused market research firm, has published a new report on the global orphan drugs market, which is expected to grow at a CAGR of more than 10% during the forecast period 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global orphan drugs market into the following key regions: the Americas, APAC,…
The global factor VIII deficiency treatment market is currently valued at around USD 9 billion and is expected to surpass USD 11 billion by 2021, says Technavio. Technavio has announced its latest market research report on the global factor VIII deficiency treatment market, under its rare and infectious diseases portfolio. This market analysis discusses…
According to the newest market research study by Technavio, the global anticoagulant market is predicted to grow at a CAGR of over 7% during the forecast period 2017 to 2021. This industry report by Technavio provides an exhaustive analysis of the global anticoagulant market in terms of revenue and developing market trends. The report also…
The global TB drug market was valued at USD 886 million in 2016 and is expected to surpass USD 1,036 million by 2021, says Technavio. Technavio has announced its latest market research report on the global TB drug market, under its infectious and rare diseases portfolio. This market analysis discusses the major drivers and…
The global antifungal drugs market was valued at USD 13 billion in 2016 and is expected to surpass USD 15 billion by 2021, says Technavio. Technavio has announced its latest market research report on the global antifungal drugs market, under its infectious and rare diseases portfolio. This market analysis discusses the major drivers and…
Technavio, a tech-focused market research firm, has published a new report on the global atopic dermatitis market, which is expected to grow at a CAGR of more than 4% during the forecast period, 2017-2021. Based on geographical segmentation, Technavio market researchers categorize the global atopic dermatitis market into the following key regions: The Americas,…
Technavio market research analysts foresee positive growth for many segments of the infectious and rare diseases industry in the next five years. In their recent market analysis, Technavio talks about three booming segments, under the automotive industry that are anticipated to generate considerable revenues and grow at a consistent rate during the forecast period. Purchase…
